11.05
price up icon6.45%   0.67
after-market After Hours: 11.11 0.06 +0.54%
loading

Helus Pharma Inc Stock (HELP) Forecast

The Helus Pharma Inc (HELP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $9.8103, representing a -11.22% decrease from the current price of $11.05. The highest analyst price target is $10.90, and the lowest is $8.7238.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HELP Price Target
Average 13.06 (+18.15% Upside)
loading

Is Helus Pharma Inc (HELP) A Buy Now?

Oscillators
Name Value Action
RSI(14) 45.19 Neutral
STOCH(9,6) 30.22 Neutral
STOCHRSI(14) 57.57 Neutral
MACD(12,26) -0.4119 Sell
ADX(14) 21.01 Neutral
William %R -63.94 Neutral
CCI(14) -41.75 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
10.99
Buy
11.12
Sell
MA20
11.87
Sell
11.55
Sell
MA50
12.13
Sell
11.27
Sell
MA100
9.091
Buy
9.9578
Buy
MA200
7.4338
Buy
0.00
Buy
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, HELP could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on HELP, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 45.19 indicates that HELP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 30.22 indicates that HELP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 57.57 indicates that HELP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 21.01 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -41.75 indicates that HELP is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term HELP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Helus Pharma Inc financial reports and earnings history, Helus Pharma Inc (HELP) stock could reach $26.12 by 2030, $71.31 by 2040 and $94.53 by 2050. See the projected annual prices until 2050 of the Helus Pharma Inc stock below:

  • Helus Pharma Inc (HELP) is expected to reach an average price of $37.87 in 2035, with a high prediction of $38.75 and a low estimate of $36.79. This indicates an $242.72% rise from the last recorded price of $11.05.
  • Helus Pharma Inc (HELP) stock is projected to chart a bullish course in 2040, with an average price target of $53.35, representing an $382.77% surge from its current level. The forecast ranges from a conservative $52.46 to a sky-high $71.31.
  • Our analysts predict Helus Pharma Inc (HELP) to jump 701.66% by 2045, soaring from $81.02 to an average price of $88.58, potentially reaching $88.62. While $81.02 is the low estimate, the potential upside is significant.
  • Helus Pharma Inc (HELP) stock is expected to climb by 2050, reaching an average of $94.29, a $753.30% jump from its current level. However, a wide range of estimates exists, with high and low targets of $94.53 and $91.62, respectively, highlighting the market's uncertainty.

Helus Pharma Inc Stock (HELP) Year by Year Forecast

Helus Pharma Inc Stock (HELP) Price Forecast for 2026

The predicted value for Helus Pharma Inc (HELP) in 2026 is set at an average of $9.455. Estimates vary from a peak of $15.15 to a trough of $3.76, indicating an -14.43% surge from the present price of $11.05.
Month Average Low High Change from today's price
November, 2026 $9.8007 $8.7238 $10.90 -11.31%
December, 2026 $7.7045 $7.6045 $11.59 -30.28%

Helus Pharma Inc Stock (HELP) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Helus Pharma Inc (HELP) is $13.06, with a high forecast of $18.94 and a low forecast of $7.1728. This indicates an +18.15% increase from the last price of $11.05.
Month Average Low High Change from today's price
January, 2027 $8.3983 $7.4214 $8.6283 -24.00%
February, 2027 $8.4221 $8.0752 $9.5072 -23.78%
March, 2027 $7.5393 $7.4593 $8.8455 -31.77%
April, 2027 $10.09 $7.1728 $10.54 -8.66%
May, 2027 $11.41 $9.30 $12.03 +3.26%
June, 2027 $15.87 $11.14 $18.04 +43.66%
July, 2027 $16.16 $14.97 $18.94 +46.23%
August, 2027 $14.29 $13.88 $18.05 +29.28%
September, 2027 $12.46 $12.36 $14.67 +12.77%
October, 2027 $13.38 $11.67 $13.86 +21.07%
November, 2027 $11.06 $10.55 $14.62 +0.12%
December, 2027 $12.06 $11.11 $12.63 +9.14%

Helus Pharma Inc Stock (HELP) Price Forecast for 2028

In 2028, Helus Pharma Inc (HELP) is projected to reach an average price of $16.66, with a high projection of $22.73 and a low estimate of $10.59. This indicates an +50.73% rise from the last price of $11.05.
Month Average Low High Change from today's price
January, 2028 $11.36 $10.83 $12.76 +2.85%
February, 2028 $11.54 $10.59 $11.63 +4.46%
March, 2028 $13.93 $11.67 $14.03 +26.06%
April, 2028 $18.86 $13.51 $18.87 +70.66%
May, 2028 $19.70 $17.13 $21.74 +78.30%
June, 2028 $19.96 $19.45 $22.73 +80.63%
July, 2028 $16.36 $15.41 $20.54 +48.06%
August, 2028 $14.99 $14.61 $16.69 +35.67%
September, 2028 $13.82 $13.82 $17.66 +25.10%
October, 2028 $14.75 $13.68 $14.98 +33.53%
November, 2028 $14.97 $14.53 $16.00 +35.44%
December, 2028 $14.65 $14.18 $15.44 +32.56%

Helus Pharma Inc Stock (HELP) Price Forecast for 2029

The 2029 price forecast for Helus Pharma Inc Stock (HELP) is $20.26 on average, with a high prediction of $26.51 and a low estimate of $14.00. This represents an +83.31% increase from the previous price of $11.05.
Month Average Low High Change from today's price
January, 2029 $17.06 $14.00 $17.51 +54.38%
February, 2029 $18.35 $16.36 $19.18 +66.07%
March, 2029 $23.60 $18.14 $23.96 +113.59%
April, 2029 $23.73 $22.41 $26.51 +114.79%
May, 2029 $23.45 $21.84 $25.67 +112.18%
June, 2029 $19.13 $18.26 $24.45 +73.10%
July, 2029 $19.41 $17.56 $19.89 +75.63%
August, 2029 $16.95 $16.84 $20.70 +53.41%
September, 2029 $18.31 $16.82 $18.60 +65.67%
October, 2029 $17.95 $17.75 $19.25 +62.41%
November, 2029 $17.95 $17.41 $18.31 +62.45%
December, 2029 $20.99 $17.83 $21.09 +89.96%

Helus Pharma Inc Stock (HELP) Price Forecast for 2030

Helus Pharma Inc Stock (HELP) is expected to reach an average price of $25.62 in 2030, with a high forecast of $31.30 and a low forecast of $19.94. This signifies an +131.88% surge from the last price of $11.05.
Month Average Low High Change from today's price
January, 2030 $26.11 $20.61 $26.12 +136.25%
February, 2030 $26.63 $24.42 $29.13 +141.00%
March, 2030 $27.86 $26.35 $30.30 +152.09%
April, 2030 $21.78 $21.11 $28.35 +97.10%
May, 2030 $20.70 $20.50 $22.60 +87.32%
June, 2030 $20.44 $20.43 $23.74 +84.96%
July, 2030 $20.89 $19.94 $21.16 +89.09%
August, 2030 $21.55 $20.90 $22.50 +95.05%
September, 2030 $21.38 $20.86 $22.03 +93.48%
October, 2030 $23.78 $20.82 $23.90 +115.19%
November, 2030 $25.02 $23.42 $25.25 +126.40%
December, 2030 $30.94 $24.96 $31.30 +180.03%
$6.31
price up icon 4.13%
DNA DNA
$11.76
price up icon 1.99%
$1.23
price up icon 3.36%
SGP SGP
$24.72
price up icon 4.35%
$16.79
price up icon 3.64%
$9.85
price up icon 5.01%
Cap:     |  Volume (24h):